x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The BioHub: The Top Voices in Biotech

Max Brennan - Biotech HeadHunter

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that"s shaping the future of biotechnology. Get ready for an immersive

science life sciences

All Episodes

00:14:32

Episode 103 - Justin To - CEO of QED Therapeutics, a...

The BioHub: The Top Voices in Biotech ·

2025/12/19

Today’s guest is Justin To, a leader at the forefront of biotech innovation and gene therapy. Justin currently serves as CEO of QED Therapeutics, a BridgeBio company, where he helps guide the development of treatments for rare genetic diseases.With a background that spans strategy consulting at McKinsey, healthcare technology at Flatiron Health, and multiple leadership roles at BridgeBio, Justin brings a unique blend of scientific rigor, operational leadership, and business insight. He’s worked

en

00:23:27

Episode 102 - Miquel Vila-Perello - CEO of SpliceBio

The BioHub: The Top Voices in Biotech ·

2025/12/19

We recently sat down with Miquel Vila-Perello, CEO of SpliceBio, at Jefferies - during which the team picked up the Series B Raise of the Year at the 2025 ELAs for their $135million round earlier this year. SpliceBio are a Barcelona-based gene therapy company using a proprietary Protein Splicing platform to address diseases caused by large genes that traditional AAV vectors can’t deliver. Their lead program, SB-007 for Stargardt disease, is currently being investigated in their Phase 1/2 ASTRA

en

00:39:34

Episode 101 - Jason Cole - CEO of ZagBio

The BioHub: The Top Voices in Biotech ·

2025/12/18

We were delighted to be joined by Jason Cole, a seasonedbiotechnology executive and the CEO of Zag Bio, a Cambridge-based biotech company taking a novel approach to autoimmune disease, onto The BioHub!Jason brings more than two decades of leadership experience across the biotech industry, spanning company formation, drug development, corporate strategy, and commercialization. Before joining Zag Bio, he heldsenior executive roles at several innovative life-science companies, including bluebird bio,

en

00:15:45

Episode 100 - Lance Baldo - CEO of Beacon Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/12/16

We recently spoke to Lance Baldo, CEO of Beacon Therapeutics, during the Jefferies Healthcare Conference. Beacon's Vista ph3 trial for laru-zova, their AAV Gene Therapy for X-Linked Retinitis Pigmentosa, has completed enrolment with topline expected in mid-2026.Listen in to hear about Lance's career, from roles with Roche in both Switzerland & New Zealand to a return to the US with Genentech's ophthalmology division, and how he's drawn on those experiences in his role as CEO of

en

00:38:30

Episode 99 - Luba Greenwood - CEO Gallop Oncology

The BioHub: The Top Voices in Biotech ·

2025/12/15

Welcome to The BioHub Podcast.I’m joined by Luba Greenwood, CEO of Gallop.Luba’s one of the most respected voices in biotech — a three-time CEO, founder of Binney Street Capital at Dana-Farber, and a driving force behind Biotech Hangout.We talk about Gallop’s mission, what it takes to build strong culture in tough markets, and the personal motivation behind her work after losing her mum to cancer.It’s an inspiring and powerful conversation — let’s get intoit.

en

00:18:48

Episode 98 - Christian Leisner - CEO CDR Life

The BioHub: The Top Voices in Biotech ·

2025/12/09

Today we’re joined by a leader at the forefront of next-generation immunotherapy — Dr. Christian Leisner. Christian is the CEO and co-founder of CDR-Life, a biotechnology company pioneering a new class of highly targeted T-cell engaging therapies designed to tackle some of the most difficult-to-treat cancers.With a PhD in Biochemistry from ETH Zurich and a Master’s in Molecular Biology and Chemistry from Roskilde University in Denmark, Christian has built a career that bridges deep scientific

en

00:30:35

Episode 97 - Christina Coughlin - CEO Avacta...

The BioHub: The Top Voices in Biotech ·

2025/12/05

We were delighted to welcome Dr. Christina Coughlin, CEO of Avacta Therapeutics, onto The BioHub! Avacta are a clinical-stage biotech pioneering next-generation oncology therapies.With a remarkable career spanning top pharmaceutical companies and cutting-edge biotech — from Immunocore and Rubius Therapeutics to Tmunity and CytoImmune — Christina brings a unique blend of medical expertise, scientific insight, and leadership acumen. At Avacta, she is driving the development of groundbreaking

en

00:25:33

Episode 96 - Jill Howe - CFO Lineage Cell Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/12/03

Welcome to another Episode of The BiohubToday, I’m joined by Jill Howe, Chief Financial Officer at Lineage Cell Therapeutics, a company developing groundbreaking allogeneic cell therapies for conditions like dry AMD, spinal cord injury, and hearing loss.Jill’s career spans more than 20 years across some of biotech’s most successful companies, helping take both Receptos and Gossamer Bio public before stepping into her current role at Lineage.We talk about what inspired her to join the company, how

en

00:30:31

Episode 95 - Abigail Jenkins

The BioHub: The Top Voices in Biotech ·

2025/12/03

Welcome back to another episode of The BioHub, we were thrilled to introduce a guest whose career lies at the cutting edge of cell therapy, biotech leadership, and real-world impact. Abigail Jenkins is a visionary biotech CEO whose journey has taken her from pioneering the development of cell therapies to leading companies at the forefront of regenerative medicine.Before stepping into her current role, Abigail served as CEO of Gamida Cell, where she guided the company through pivotal stages of

en

00:22:21

Episode 94 - Cameron Turtle - CEO of Spyre Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/12/01

On this episode we welcomed Cameron Turtle, CEO of Spyre Therapeutics during the Jefferies Healthcare conference.Spyre are developing next-generation antibodies, engineered for prolonged activity in the body and formulated for delivery as monotherapies or combination therapies to validated inflammatory targets. Their approach has the potential to deliver uncompromising efficacy and convenience for patients in a number of autoimmune indications. This podcast was recorded in November 2025. Comments

en

00:27:40

Episode 93 - Brendan Teehan - CCO Pacira Biosciences

The BioHub: The Top Voices in Biotech ·

2025/11/26

Today on The BioHub, I’m joined by Brendan Teehan, Chief Commercial Officer at Pacira BioSciences.Brendan has spent three decades building and leading commercial teams across biopharma, from Johnson & Johnson to Amgen, Tesaro, and Acadia. Now at Pacira, he’s driving the company’s mission to transform pain management through innovative non-opioid therapies.In this conversation, we get into what inspired him to join Pacira, how the company has evolved, and how they’ve aligned the entire

en

00:33:02

Episode 92 - Luc Dochez - Managing Partner at Droia...

The BioHub: The Top Voices in Biotech ·

2025/11/25

Today we’re joined by one of Europe’s most respected builders of biotechnology companies — Luc Dochez.Luc is a scientist-turned-entrepreneur whose career has helped shape the next generation of therapies in oncology, rare diseases, and genetic medicine. Over the past two decades, he has co-founded and led multiple biotech companies, including Vico Therapeutics, Montis Biosciences, and Pharvaris, and he served as CEO of Tusk Therapeutics, guiding it all the way to its acquisition by Roche.Before

en

00:17:44

Episode 91 - Sten Sörensen - Cereno Scientific

The BioHub: The Top Voices in Biotech ·

2025/11/24

en

00:42:20

Episode 90 - Andrea DiMella - Atlas Venture

The BioHub: The Top Voices in Biotech ·

2025/11/14

On this episode we're joined by Andrea DiMella - VP & Head of Talent at Atlas Venture - to get her insight into the evolving talent landscape in biotechnology.We talk through Andrea's transition from a laboratory scientist into a transformative TA leader through roles with Genentech, Biogen, Third Rock, and now Atlas Venture. Her learnings throughout this journey are shaping the TA strategy of some of the most exciting biotechs in the Atlas portfolio. Tune in to hear more about

en

00:25:25

Episode 89 - Rita Balice-Gordon - Muna Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/11/12

Rita is the CEO of Muna Therapeutics, a biotech company focused on discovering and developing therapies that restore the function of diseased neurons and slow or stop neurodegeneration.In this conversation, we explore Rita’s career journey and what inspired their move into biotech leadership, as well as what first drew them to Muna Therapeutics. We talk about Muna’s scientific focus, how their approach to neurodegenerative diseases stands apart, and what it takes to lead a globally distributed

en

00:28:39

Episode 88 - Robert Hoffman - CFO Cytodyn

The BioHub: The Top Voices in Biotech ·

2025/11/11

Today on The BioHub, I’m joined by Robert Hoffman, Chief Financial Officer of CytoDyn.Robert is a true industry veteran — with decades ofexperience leading finance and strategy across some of biotech’s most recognizable names, from Arena to Heron and Kintara. Over his career he’s guided IPOs, spin-offs, fundraises, and M&A, all while serving on the boards of multiple biotech companies.Now at CytoDyn, Robert is helping steer the company as itadvances its lead monoclonal antibody program.This

en

00:33:53

Episode 87 - Sheila Gujrathi

The BioHub: The Top Voices in Biotech ·

2025/11/11

Today, we’re joined by an extraordinary leader who has spent her career at the intersection of science, innovation, and human potential — Dr. Sheila Gujrathi.Sheila is a physician, scientist, engineer, and biotech entrepreneur whose journey embodies both precision and purpose. She earned her Bachelor’s degree in Biomedical Engineering and her M.D. from Northwestern University, before completing her residency at Brigham and Women’s Hospital / Harvard Medical School and fellowships in Allergy and

en

00:24:13

Episode 86 - David de Vries - Tr1X

The BioHub: The Top Voices in Biotech ·

2025/11/07

On this episode we're joined by the Co-Founder & CEO of Tr1X, David de Vries. David and the team are building on the Nobel Prize winning research into T-reg cells of Fred Ramsdell, Shimon Sakaguchi, and Mary Brunkow, pushing that science forward by translating a Type-1 regulatory T cell program into the clinic with one goal - lasting immune balance for patients. Their lead program TRX103 is in ph1/2 trials for GvHD and Refractory Crohn's, whilst they just received another IND clearance

en

00:26:57

Episode 85 - Neha Krishnamohan - CFO & EVP Corporate...

The BioHub: The Top Voices in Biotech ·

2025/11/06

We were honoured to welcome Neha Krishnamohan, onto The BioHub.Neha began her professional journey at Goldman Sachs in theHealthcare Investment Banking Group, focusing on mergers & acquisitions and strategic financings for biotech and med-tech companies. During her time there, she helped execute more than $100 billion in transactions across biopharma, diagnostics and tools.Building on that foundation, Neha then moved into anoperational leadership role in biotech: she served as CFO and Executive

en

00:22:08

Episode 84 - Tord Labuda - CEO of Alzinova

The BioHub: The Top Voices in Biotech ·

2025/10/30

On this episode of the BioHub Podcast we’re joined by the CEO of Alzinova, Tord Labuda. Alzinova are a Gothenburg-based biotech developing an Alzheimer’s vaccine that's just received FDA IND approval and will soon step into ph2 trials. Alzinova’s products have been developed using their proprietary AβCC peptide™ technology. The technology entails covalent restriction of the amyloid-β (Aβ) peptide so that it only forms the soluble (Aβ) toxins (oligomers/protofibrils) that play a central role in

en

129 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter